Marquant Partners provides transaction and strategic advisory services to companies and to investors in the biotechnology and pharmaceutical industry. We combine significant transaction experience, extensive industry knowledge and deep relationships in a multicultural setting.
We execute and deliver successful;- inward and outward licensing transactions
- mergers
- acquisitions
- divestments
- exit strategies
- growth strategies
- general advisory
- valuation projects
We aim, on every engagement, to exceed what is expected of us.
Our clients are predominantly private, or are companies with a small market capitalization, who are involved in the development of novel branded prescription medicines or who are developing new technology platforms serving the life sciences.
- we listen carefully to our clients needs
- we play well with others
- we bring a high level of attentive detailed service to every client on every engagement
- we only take on engagements where we are sure we can add value
The Marquant team’s unique combination of backgrounds allows us to provide a set of services that maximize the efficiency of transactions, and our deep industry experience ensures that our strategic advice works.
We aim to forge long term relationships with our clients as they grow and evolve.
